May 1, 2013
Torii Pharmaceutical will launch the anti-HIV drug Stribild Combination Tablets in Japan on May 14. Stribild is a fixed-dose combination drug containing four compounds – elvitegravir, the nucleotide analog reverse tanscriptase inhibitors emtricitabine and tenofovir disoproxil fumarate, and cobicistat, which...read more